BactiQuant A/S
BACTIQ.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | DKK 7 | DKK 12 | DKK 12 | DKK 8 |
| % Growth | -41.7% | -0.7% | 48.2% | – |
| Cost of Goods Sold | DKK 19 | DKK 13 | DKK 25 | DKK 20 |
| Gross Profit | -DKK 12 | -DKK 1 | -DKK 13 | -DKK 12 |
| % Margin | -161.4% | -6.1% | -103.2% | -143% |
| R&D Expenses | DKK 1 | DKK 0 | DKK 1 | DKK 1 |
| G&A Expenses | DKK 0 | DKK 0 | -DKK 11 | -DKK 9 |
| SG&A Expenses | DKK 0 | DKK 0 | -DKK 11 | -DKK 9 |
| Sales & Mktg Exp. | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Other Operating Expenses | DKK 0 | DKK 10 | -DKK 16 | DKK 9 |
| Operating Expenses | DKK 1 | DKK 10 | -DKK 26 | DKK 1 |
| Operating Income | -DKK 13 | -DKK 11 | -DKK 14 | -DKK 13 |
| % Margin | -176.2% | -88.6% | -110.4% | -151.7% |
| Other Income/Exp. Net | -DKK 1 | -DKK 2 | -DKK 1 | -DKK 1 |
| Pre-Tax Income | -DKK 14 | -DKK 13 | -DKK 14 | -DKK 13 |
| Tax Expense | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Net Income | -DKK 14 | -DKK 13 | -DKK 14 | -DKK 14 |
| % Margin | -191.3% | -106.5% | -114.5% | -162.1% |
| EPS | -0.52 | -0.64 | -0.72 | -0.71 |
| % Growth | 18.8% | 11.1% | -1.4% | – |
| EPS Diluted | -0.52 | -0.64 | -0.72 | -0.71 |
| Weighted Avg Shares Out | 26 | 21 | 20 | 19 |
| Weighted Avg Shares Out Dil | 26 | 21 | 20 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Interest Expense | DKK 1 | DKK 2 | DKK 1 | DKK 1 |
| Depreciation & Amortization | DKK 1 | DKK 0 | DKK 0 | DKK 0 |
| EBITDA | -DKK 12 | -DKK 11 | -DKK 13 | -DKK 12 |
| % Margin | -163.1% | -90.4% | -106.4% | -149.1% |